Stephen Doster

  • Vanderbilt University

    Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease—too much of a good thing

    by Marissa Shapiro Oct. 27, 2020, 9:00 AM Vanderbilt researchers—including Charles Sanders, associate dean for research and professor of biochemistry, and graduate student Justin Marinko—have illuminated the cause of Charcot-Marie-Tooth disease, putting them on the road to developing therapeutic approaches for the disease that… Read More

    Oct. 28, 2020

  • Vanderbilt University

    New faculty Rick Sando: A better understanding of brain circuitry

    Oct. 26, 2020, 2:30 PM MyVU is spotlighting a select group of new faculty for 2020-21. Read more profiles in the series. By Lorena Infante Lara Our brains function thanks to billions of connections between neurons firing off at the right time and in the right… Read More

    Oct. 28, 2020

  • Vanderbilt University

    Breann Brown featured in ASMBMTODAY

    Mixing mitochondrial biology, mentoring — and doughnuts Breann Brown works to be honest about the Black experience in academia without scaring talented students away from science. By Leia Dwyer October 19, 2020 The phrase “the mitochondria is the powerhouse of the cell” has a jokey reputation in American education as… Read More

    Oct. 22, 2020

  • Vanderbilt University

    Interdisciplinary melanoma research brings understanding of cellular resistance to cancer treatment, opening doors to new cures

    by Marissa Shapiro Oct. 21, 2020, 12:00 PM A Vanderbilt cancer systems biology team has identified the enzymes that keep tumor cells growing in the presence of drug treatment, opening the door to stopping these cells dead in their tracks. An article, “An… Read More

    Oct. 22, 2020

  • Vanderbilt University

    Preserving gut mucus architecture

    Oct. 20, 2020, 8:00 AM by Leigh MacMillan Interactions between microbes and host cells in the gastrointestinal tract have been implicated in the development and progression of colorectal cancer. Current techniques to study gut microbes and host cells preserve these populations separately, removing the opportunity to explore spatial interactions between… Read More

    Oct. 22, 2020

  • Vanderbilt University

    ‘Black in Cancer’ promotes diversity in research

    Oct. 21, 2020, 3:45 PM   by Tom Wilemon Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception. Henry Henderson III, PhD “Black in Cancer Week,” held Oct. 11-17, focused… Read More

    Oct. 21, 2020

  • Lindsley are among four faculty working in the Vanderbilt Warren Center for Neuroscience Drug Discovery on a new drug, VU319, to treat Alzheimer's disease.

    Craig Lindsley named director of Warren Center for Neuroscience Drug Discovery

    by Ryan Underwood Oct. 20, 2020, 11:50 AM Craig Lindsley, the William K. Warren, Jr. Chair in Medicine and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of the Warren Center for Neuroscience Drug Discovery, effective Dec. 1. (John Russell/Vanderbilt)… Read More

    Oct. 21, 2020

  • New faculty Nancy Carrasco - Molecular Physiology, in her lab at Light Hall for Vanderbilt Magazine.

    Carrasco elected to the National Academy of Medicine

    Oct. 20, 2020, 8:45 AM by Bill Snyder Three members of the Vanderbilt University School of Medicine faculty have been elected this year to the National Academy of Medicine (NAM), the organization announced Monday, Oct. 19. They are: Nancy Carrasco, MD, professor and chair of the Department of… Read More

    Oct. 20, 2020

  • Ian Macara

    Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapy’s impact on tissue growth

    by Marissa Shapiro Oct. 15, 2020, 12:00 PM Vanderbilt University researchers have reported the counterintuitive discovery that certain chemotherapeutic agents used to treat tumors can have the opposite effect of tissue overgrowth in normal, intact mammary glands, epidermis and hair follicles. The researchers also… Read More

    Oct. 15, 2020

  • Robert J. Coffey GI Medicine/Oncology GI SPORE Cancer research

    Possible COVID-19 “decoy”

    Oct. 15, 2020, 10:00 AM by Bill Snyder The novel coronavirus, SARS-CoV-2, must bind to the cell surface receptor ACE2 to enter cells and cause infection. Recently a preclinical study by an international research team found that the presence of a recombinant soluble form of human ACE2 reduced viral growth and inhibited infection. This raises… Read More

    Oct. 15, 2020